Gennex Laboratories closes trading window from July 01, 2026

1 min read     Updated on 23 Jun 2026, 06:11 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Gennex Laboratories Limited has closed its trading window from July 01, 2026, until 48 hours after the announcement of its unaudited Q1FY27 results. The move follows SEBI regulations to prevent insider trading. The board meeting date to approve the financial results will be announced later.

powered bylight_fuzz_icon
43764081

*this image is generated using AI for illustrative purposes only.

Gennex Laboratories has closed its trading window for dealing in the company's securities effective July 01, 2026. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The restriction is intended to prevent insider trading while the company prepares to release its financial performance data for the recent quarter.

The trading window will remain shut until 48 hours after the public announcement of the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The closure period is standard practice to ensure that sensitive information is not misused ahead of formal disclosures. The specific date for the Board of Directors meeting to approve these results has not yet been finalized and will be informed in due course.

Consequently, all promoters, designated persons, and connected persons have been advised not to trade in the securities of Gennex Laboratories Limited either directly or indirectly during this period. The company has communicated this regulatory compliance to the BSE Limited, The Ahmedabad Stock Exchange Limited, and The Calcutta Stock Exchange Limited to ensure the information is placed on record.

Key Compliance Details

Detail Information
Regulation SEBI (Prohibition of Insider Trading) Regulations, 2015
Trading Window Closure July 01, 2026
Reopening 48 hours after Q1FY27 results announcement
Period Covered First Quarter ended June 30, 2026
Results Type Un-audited Standalone and Consolidated

Historical Stock Returns for Gennex Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.12%-10.37%-19.53%-14.30%+12.00%

How might the extended trading window closure impact liquidity in Gennex Laboratories' stock until the Q1 results are released?

What market expectations are currently priced into Gennex Laboratories' stock ahead of the upcoming unaudited financial results?

Could the delay in finalizing the Board meeting date signal any underlying complexities in finalizing the Q1 financial data?

Gennex Laboratories promoter pledges shares for business loan

1 min read     Updated on 10 Jun 2026, 04:59 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Premier Fiscal Services Private Limited, a promoter of Gennex Laboratories Limited, pledged 25,00,000 equity shares (1.029%) to Vidya Tradecon Private Limited on June 9, 2026, to secure a business loan of Rs. 1.25 crore. The pledge, expiring on December 7, 2026, provides a security cover ratio of 2.0 based on the pledged shares' value of Rs. 2.50 crore. Following this transaction, the promoter's total encumbered shares increased to 1,25,00,000, representing 5.145% of the total share capital.

powered bylight_fuzz_icon
42635632

*this image is generated using AI for illustrative purposes only.

Premier Fiscal Services Private Limited, a promoter group entity of Gennex Laboratories Limited , has pledged 25,00,000 equity shares to secure a business loan. The disclosure was submitted to BSE Limited on June 10, 2026, under Regulation 31(1) and (2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The pledge was created in favor of Vidya Tradecon Private Limited on June 9, 2026. The transaction involves 25,00,000 shares, representing 1.029% of the total share capital of Gennex Laboratories Limited. The pledge is set to expire on December 7, 2026.

Details of the Encumbrance

The filing outlines the specifics of the pledge, including the purpose and the financial coverage. The shares were deposited with BMD Securities Limited, with a specific DP ID and Client ID assigned for the transaction.

Pledgee No. of Shares % of Total Share Capital Type of Encumbrance Pledge Expiry Date
M/s. Vidya Tradecon Pvt. Ltd 25,00,000 1.029 Pledge December 07, 2026

Financials and Security Cover

The primary reason for the encumbrance is availing a business loan amounting to Rs. 1.25 crore. The value of the pledged shares on the date of the event was Rs. 2.50 crore, resulting in a security cover ratio of 2.0. The borrowed amount is intended for temporary business funding.

Prior to this transaction, Premier Fiscal Services Private Limited held 5,30,38,000 shares, representing 21.831% of the total share capital. Out of this, 1,00,00,000 shares were already encumbered. With the addition of the new pledge, the total encumbered shares held by the promoter now stand at 1,25,00,000, or 5.145% of the total share capital.

Historical Stock Returns for Gennex Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.12%-10.37%-19.53%-14.30%+12.00%

What specific business initiatives will the Rs. 1.25 crore loan fund?

How will the increased promoter encumbrance impact investor confidence in Gennex Laboratories?

What are the implications if the pledged shares face a significant value decline before the December expiry?

More News on Gennex Laboratories

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-14.30%